The Limited Times

Now you can see non-English news...

Health: how France is pushing start-ups to hatch the champions of tomorrow

2023-03-23T19:16:52.788Z


Twenty innovative companies have been selected to join French Tech's Health20 program. What do Epilab, which markets a portable tuberculosis diagnostic test, Milvue, specialist in artificial intelligence in medical imaging, Nosopharm, developer of new anti-infective drugs, and Pixee Medical, which designs knee prostheses, have in common? ? These health start-ups are among the twenty winners selected for the Health20, whose names will be revealed this Friday. A French Tech program, t


What do Epilab, which markets a portable tuberculosis diagnostic test, Milvue, specialist in artificial intelligence in medical imaging, Nosopharm, developer of new anti-infective drugs, and Pixee Medical, which designs knee prostheses, have in common? ?

These health start-ups are among the twenty winners selected for the Health20, whose names will be revealed this Friday.

A French Tech program, the Health20 aims to bring out French technological champions in the health sector.

After Green20, Agri20 and DeepNum20, this is the fourth program launched by French Tech as part of its support strategy for start-ups offering breakthrough innovations on societal issues.

To be selected, these start-ups had to see their service or product demonstrate a very high level of differentiation compared to existing solutions, and a potential for large-scale deployment...

This article is for subscribers only.

You have 78% left to discover.

Want to read more?

Unlock all items immediately.

Without engagement.

TEST FOR €0.99

Already subscribed?

Login

Source: lefigaro

All business articles on 2023-03-23

You may like

Life/Entertain 2024-03-07T12:26:11.309Z
Life/Entertain 2024-03-14T18:16:08.711Z
Life/Entertain 2024-03-07T04:09:16.251Z
Life/Entertain 2024-03-06T04:25:22.361Z
Life/Entertain 2024-03-01T17:34:44.788Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.